MINDY WADE: Open Payments
NPI 1760036024 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 36 payments from 14 companies in 2025. Trend: 2023 $733 · 2024 $703 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $241 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Lilly USA, LLC | 3 | $50 |
| Exact Sciences Corporation | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Exeltis, USA Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: VRAYLAR, Symbravo, QULIPTA, CAPLYTA, Cologuard Collection Kit, UBRELVY, TRINTELLIX, Dexcom G6 Transmitter.
Industry payments across UT — which companies pay providers there.
